Risk Factors for diarrhea associated with Clostridium difficile in patients at a clinical hospital
- 作者: Yarushina Y1, Kolotova G1,2, Rudnov V1,2, Bagin V1
-
隶属关系:
- City Clinical Hospital №40
- Ural State Medical University
- 期: 卷 91, 编号 11 (2019)
- 页面: 20-25
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33685
- DOI: https://doi.org/10.26442/00403660.2019.11.000337
- ID: 33685
如何引用文章
全文:
详细
作者简介
Y Yarushina
City Clinical Hospital №40
Email: yarushina.ya@yandex.ru
врач-гастроэнтеролог гастроэнтерологического отд-ния МАУ «ГКБ №40»; ORCID:0000-0002-6333-1291 Yekaterinburg, Russia
G Kolotova
City Clinical Hospital №40; Ural State Medical Universityд.м.н., зам. главного врача по медицинской помощи МАУ «ГКБ №40» Yekaterinburg, Russia
V Rudnov
City Clinical Hospital №40; Ural State Medical Universityд.м.н., проф., зав. каф. анестезиологии и реаниматологии ГБОУ ВПО «Уральский государственный медицинский университет» Минздрава России; зам. главного врача по анестезиологии и реанимации МАУ «ГКБ №40» Yekaterinburg, Russia
V Bagin
City Clinical Hospital №40к.м.н., зав. отд-нием анестезиологии и реанимации №5 МАУ «ГКБ №40» Yekaterinburg, Russia
参考
- Pepin J, Valiquette M.E, Alary P, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D. Clostridium difficile - associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466-72. doi: 10.1503/cmaj.1041104
- Lessa F.C, Mu Y, Bamberg W.M, Beldavs Z.G, Dumyati G.K, Dunn J.R, Farley M.M, Holzbauer S.M, Meek J.I, Phipps E.C, Wilson L.E, Winston L.G, Cohen J.A, Limbago B.M, Fridkin S.K, Gerding D.N, Mc-Donald L.C. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-34. doi: 10.1056/NEJMoa1408913
- Kurti Z, Lovasz B.D, Mandel M.D, Csima Z, Golovics P.A, Csako B.D, Mohas A, Gönczi L, Gecse K.B, Kiss L.S, Szathmari M, Lakatos P.L. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol. 2015;21(21):6728-35. doi: 10.3748/wjg.v21.i21.6728
- Shivashankar R, Khanna S, Kammer P.P, Harmsen W.S, Zinsmeister A.R, Baddour L.M, Pardi D.S. Clinical factors associated with development of severe - complicated Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11(11):1466-71. doi: 10.1016/j.cgh.2013.04.050
- Shivashankar R, Khanna S, Kammer P.P, Harmsen W.S, Zinsmeister A.R, Baddour L.M, Pardi D.S. Clinical predictors of recurrent Clostridium difficile infection in out - patients. Aliment Pharmacol Ther. 2014;40(5): 518-22. doi: 10.1111/apt.12864
- Gash K, Brown E, Pullyblank A. Emergency subtotal colectomy for fulminant Clostridium difficile colitis - is a surgical solution considered for all patients? Ann R Coll Surg Engl. 2010;92(1):56-60. doi: 10.1308/00358 8410X12518836439164
- Slimings C, Riley T.V. Antibiotics and hospital - acquired Clostridium difficile infection: update of systematic review and meta - analysis. J Antimicrob Chemother. 2014;69(4):881-91. doi: 10.1093/jac/dkt477
- Oh S.E, Lee S.M, Lee Y-K, Choi S.R, Choi M-J, Kim J-K, Song Y.R, Kim S.J, Park T.J, Kim S.G, Oh J, Suh.JW, Yoon J-W, Koo J-R, Kim H.J, Noh J.W. Clostridium difficile - associated diarrhea in dialysis patients. Kydney Res Clin Pract. 2013;32(1):2731. doi: 10.1016/j.krcp.2012.12.002
- Gweon T.G, Choi M.G, Baeg M.K, Lim C.H, Park J.M, Lee I.S, Kim S.W, Lee D.G, Park Y.J, Lee J.W. Hematologic diseases: High risk of Clostridium difficile associated diarrhea. World J Gastroenterol. 2014;20(21):6602-7. doi: 10.3748/wjg.v20.i21.6602
- Nitzan O, Elias M, Chazan B, Raz R, Saliba W. Clostridium difficile and inflammatory bowel disease: Role in pathogenesis and implications in treatment. World J Gastroenterol. 2013;19(43):7577-85. doi: 10.3748/wjg. v19.i43.7577
- Hainesa С.F, Moorea R.D, Bartletta J.G, Searsa C.L, Cosgrovea S.E, Carrollb K, Gebo K.A. Clostridium difficile in a HIV-Infected Cohort: Incidence, Risk Factors, and Clinical Outcomes. AIDS. 2013;27(17):2799-807. doi: 10.1097/01.aids.0000432450.37863.e9
- Bone R.C, Sibbald W.J, Sprung C.L. The ACCPSCCM consensus conference on sepsis and organ failure. Chest. 1992;101(6):1481-3. doi: 10.1378/chest.101.6.1481
- Charlson M.E, Pompei P, Ales K.L, Mac Kenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681 (87)90171-8
- Asempa T.E, Nicolau D.P. Clostridium difficile infection in the elderly: an update on management. Clinical Interventions in Aging. 2017;12:1799-809. doi: 10.2147/CIA.S149089
- Othman F, Crooks C.J, Card T.R. The risk of Clostridium difficile infection in patients with pernicious anaemia: a retrospective cohort study using primary care database. United European Gastroenterology J. 2017; 5(7):959-66. doi: 10.1177/2050640617695697
- Dallman P.R. Iron deficiency and the immune response. Am J Clin Nutr. 1987;46(2):329-34. doi: 10.1093/ajcn/46.2.329
- Helyar L, Sherman A.R. Iron deficiency and interleukin 1 production by rat leukocytes. Am J Clin Nutr. 1987;46(2):346-52. doi: 10.1093/ajcn/46.2.346
- Dudzicz S, Adamczak M, Więcek A. Clostridium Difficile Infection in the Nephrology Ward. Kidney Blood Press Res. 2017;42(5):844-52. doi: 10. 1159/000484428
- Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B. Aspects of Immune Dysfunction in End - stage Renal Disease. Clin J Am Soc Nephrol. 2008;3(5):1526-33. doi: 10.2215/CJN.00950208
- Trifan A, Stanciu C, Girleanu I, Stoica O.A, Singeap A.M, Maxim R, Chiriac S.A, Ciobica A, Boiculese L. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta - analysis. World J Gastroenterol. 2017;23(35):6500-15. doi: 10.3748/wjg.v23.i35.6500
- Janarthanan S, Ditah I, Adler D.G, Ehrinpreis M.N. Clostridium difficile - associated diarrhea and proton pump inhibitor therapy: a meta - analysis. Am J Gastroenterol. 2012;107:1001-10. doi: 10.1038/ajg.2012.179
- Khanna S, Aronson S.L, Kammer P.P, Baddour L.M, Pardi D.S. Gastric acid suppression and outcomes in Clostridium difficile infection: a population - based study. Mayo Clin Proc. 2012;87(7):636-42. doi: 10.1016/j.mayocp. 2011.12.021
- Leonard A.D, Ho K.M, Flexman J. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case - control study. Intern Med J. 2012;42(5):591-4. doi: 10.1111/j.1445-5994. 2012.02770.x
- Stevens V, Dumyati G, Fine L.S, Fisher S.G, Wijngaarden E. Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection. Clinical Infectious Diseases. 2011;53(1):42-8. doi: 10.1093/cid/ cir301
- Slimings C, Riley T.V. Antibiotics and hospital - acquired Clostridium difficile infection: update of systematic review and meta - analysis. J Antimicrob Chemother. 2014;69(4):881-91. doi: 10.1093/jac/dkt477